Computed tomography assessment of early response to neoadjuvant therapy in colon cancer

Keyphrases

• Computed Tomography 100%
• Colon Cancer 100%
• Early Response 100%
• Neoadjuvant Therapy 100%
• 95% Confidence Interval 100%
• Tumor Invasion 37%
• Enlarged Lymph Nodes 37%
• Tumor Size 25%
• Tumor 12%
• Progressive Disease 12%
• Drug Therapy 12%
• Multidetector Computed Tomography 12%
• Distant Metastasis 12%
• Oxaliplatin 12%
• Capecitabine 12%
• KRAS mutation 12%
• Stable Disease 12%
• 3-cycle 12%
• Tumor number 12%
• Tumor Diameter 12%
• Neoadjuvant 12%
• BRAF Gene 12%
• Panitumumab 12%
• Tumor Length 12%
• Locally Advanced Colon Cancer 12%
• IV Contrast 12%
• Preoperative Treatment 12%
• Invasion numbers 12%
• PIK3CA Gene 12%
• Modified Response Evaluation Criteria in Solid Tumors (mRECIST) 12%
• Peritoneal Nodules 12%

Medicine and Dentistry

• Computer Assisted Tomography 100%
• Colon Carcinoma 100%
• Neoadjuvant Therapy 100%
• Tumor 100%
• Tumor Invasion 75%
• Lymphadenopathy 75%
• Drug Therapy 25%
• Multidetector Computed Tomography 25%
• Progressive Disease 25%
• Distant Metastasis 25%
• Oxaliplatin 25%
• Capecitabine 25%
• Panitumumab 25%
• Preoperative Treatment 25%
• Diseases 25%
• Neutron Capture Therapy 25%